Teleflex Incorporated (NYSE:TFX) Given Consensus Rating of “Hold” by Analysts

Teleflex Incorporated (NYSE:TFX) has been assigned an average rating of “Hold” from the nine brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $144.00.

A number of brokerages have recently commented on TFX. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a research note on Monday, April 13th. Wells Fargo & Company lifted their price target on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Needham & Company LLC lifted their price target on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $150.00 price target on shares of Teleflex in a research note on Friday, May 8th.

Teleflex Stock Down 1.8%

Shares of Teleflex stock opened at $125.29 on Wednesday. The firm has a market cap of $5.55 billion, a price-to-earnings ratio of -5.50, a PEG ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. Teleflex has a 1 year low of $100.18 and a 1 year high of $139.67. The company has a 50-day moving average of $125.28 and a 200 day moving average of $117.54.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. Teleflex’s revenue was up 32.3% compared to the same quarter last year. During the same period last year, the business earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, sell-side analysts anticipate that Teleflex will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date is Friday, May 22nd. Teleflex’s payout ratio is -5.96%.

Institutional Trading of Teleflex

Several large investors have recently added to or reduced their stakes in TFX. Banque Cantonale Vaudoise grew its position in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. Hantz Financial Services Inc. grew its position in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in Teleflex during the third quarter valued at approximately $35,000. V Square Quantitative Management LLC bought a new stake in Teleflex during the fourth quarter valued at approximately $37,000. Finally, UMB Bank n.a. grew its position in Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the period. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.